• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

T Rowe Price Health Sciences Fund Inc

+ Add to Watchlist

PRHSX:US

57.27 USD 0.39 0.69%

As of 19:59:59 ET on 04/15/2014.

Snapshot for T Rowe Price Health Sciences Fund Inc (PRHSX)

Year To Date: -0.92% 3-Month: -6.07% 3-Year: +23.98% 52-Week Range: 44.12 - 66.06
1-Month: -10.01% 1-Year: +29.77% 5-Year: +28.28% Beta vs SPX: 1.00

Mutual Fund Chart for PRHSX

No chart data available.
  • PRHSX:US 57.27
  • 1M
  • 1Y
Interactive PRHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PRHSX

T. Rowe Price Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine or the life sciences.

Inception Date: 12-29-1995 Telephone: 1-800-225-5132
Managers: TAYMOUR R TAMADDON
Web Site: www.troweprice.com

Fundamentals for PRHSX

NAV (on 2014-04-15) 57.27
Assets (M) (on 2014-03-31) 9,298.23
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for PRHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-16) 0.90
Dividend Yield (ttm) 7.74

Fees & Expenses for PRHSX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.65
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 0.79

Top Fund Holdings for PRHSX

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 8,673,000 651,775,950 7.598%
Alexion Pharmaceuticals Inc 2,919,100 388,415,446 4.528%
Biogen Idec Inc 961,200 268,895,700 3.135%
UnitedHealth Group Inc 3,386,700 255,018,510 2.973%
Valeant Pharmaceuticals Intern 2,157,600 253,302,240 2.953%
Agilent Technologies Inc 4,327,830 247,508,598 2.885%
Incyte Corp Ltd 4,855,600 245,839,028 2.866%
McKesson Corp 1,409,800 227,541,720 2.653%
Pharmacyclics Inc 2,052,700 217,134,606 2.531%
AbbVie Inc 3,706,900 195,761,389 2.282%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil